Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
Academy, accurately, ADAScog, affiliated, article, attestation, auction, BA, bachelor, Background, baseline, BioCheck, Blvd, BNC, breakdown, Broadway, butyrylcholine, caregiver, Cephalon, CFO, child, Cima, classification, Click, coersive, Columbia, comment, complaint, comprehensive, confidence, COSO, County, Daewoong, deal, deconsolidation, delist, delisted, delisting, delivery, depletion, deteriorate, drawn, EEC, eighteen, endpoint, entry, Error, EU, external, fallen, fashion, feature, Feuerman, FeuermanMr, fifteen, Florida, framework, Frameworkissued, freestanding, gather, Gerald, Gordon, hearing, identical, Impression, inadequate, inInternal, input, Interview, Irving, JD, Korea, Korean, Lake, lieu, Lloyd, MacroMed, matching, maximum, men, messenger, mg, Miller, mission, misused, Morgan, multicenter, multinational, NamendaTM, NASDQ, NICE, Novadel, numerical, orderly, Outlicensed, Overview, Paul, payroll, permanent, Preferred, procedure, proforma, promoted, Proquest, Proskauer, Ranbaxy, randomly, Ratoff, reacquisition, reclassified, regimen, reliability, replicated, replied, reset, Restoration, retrospective, revalued, Rose, Salt, Schein, Science, secondary, shortened, sought, specialty, Stanley, stayed, subgroup, subscale, supervision, Supreme, Symposium, Synderman, takeover, tentative, therapy, threat, titration, Treadway, unanimously, unauthorized, unavailable, underpowered, unexpected, unqualified, Utah, validly, version, viewpoint, visit, Watson, week, women, world, xxiv, xxvi, Zealand
Removed:
abandon, accumulation, Acetyl, analog, analyze, Aquilar, assay, attempt, Australian, Austrian, Baer, banking, Belgium, bioavailability, biochemical, Branch, burytylcholinesterase, Carbamate, Cervidil, chirex, chosen, claimed, Clayton, closed, collaboration, concentrate, contracting, correlation, creditable, CRO, designing, detected, developmental, differentiate, digestive, discretion, doctorate, dosing, dozen, educational, enhance, Eseroline, Espey, examine, exclusively, formulation, fraud, generation, Gerard, Gilatide, Greig, handling, house, incubation, indemnity, infected, interact, invalidation, leased, marketability, MFMER, Monash, Monetary, nausea, Nederland, Nigel, nonstatutory, notified, NYSE, overseeing, pathological, perpetual, pertaining, Phenethylnorcymserine, plasmon, producing, provisional, Rabobank, recoup, reelected, regional, relation, rented, replacing, resonance, retained, retirement, reverse, reversion, Rhodia, Rotterdam, running, screening, sharing, shelf, spend, spent, sublicensing, Substituted, supervisor, surface, switching, Syndrome, technique, therefrom, Thiaphysovenine, Tilburg, title, tract, transferring, undergo, understood, unreimbursed, valid, vomiting, wall, warranted, Wilton
Filing tables
Filing exhibits
Horizon Pharmaceutical similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the registration statements on Form S-8 (Registration Nos. 333-98245, 333-48088, 333-103129 and 333-118729) and Form S-3 (Registration Nos. 333-76234, 333-103130, 333-109584, 333-112489, 333-114441 and 333-116080) of our report dated January 30, 2006 on our audit of the financial statements included in the 2005 annual report on Form 10-K of Axonyx Inc. We also consent to the reference to our firm in the “Experts” sections of the registration statements on Form S-3.
New York, New York
March 15, 2006